Capital Analysts LLC’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-3,343
Closed -$125K 413
2016
Q2
$125K Sell
3,343
-1,408
-30% -$52.9K 0.03% 190
2016
Q1
$192K Hold
4,751
0.04% 173
2015
Q4
$171K Hold
4,751
0.03% 181
2015
Q3
$152K Buy
4,751
+1,130
+31% +$38.5K 0.03% 199
2015
Q2
$123K Buy
3,621
+325
+10% +$10.9K 0.03% 194
2015
Q1
$112K Buy
3,296
+216
+7% +$7.53K 0.02% 196
2014
Q4
$108K Hold
3,080
0.02% 190
2014
Q3
$101K Buy
3,080
+780
+34% +$26.5K 0.02% 189
2014
Q2
$78.2K Buy
2,300
+200
+10% +$6.85K 0.02% 199
2014
Q1
$73.6K Hold
2,100
0.02% 198
2013
Q4
$76.8K Hold
2,100
0.02% 182
2013
Q3
$72.6K Hold
2,100
0.02% 180
2013
Q2
$71K Buy
+2,100
New +$69.7K 0.02% 176

Other funds holding ACH

Capital Analysts LLC's ACH Position: Q3 2016 in Review

Capital Analysts LLC sold out of Accendra Health (ACH) in Q3 2016, closing a stake of 3,343 shares — an estimated $125K sold.

Capital Analysts LLC first reported a position in ACH in Q2 2013 and held it in 13 quarters. The position peaked at $192K in Q1 2016. 285 funds tracked by Wall St. Rank hold ACH as of Q3 2016.

  • Capital Analysts LLC reported no remaining Accendra Health position as of Q3 2016 after selling out during the quarter.
  • Capital Analysts LLC sold 3,343 Accendra Health shares in Q3 2016, an estimated $125K.
  • Capital Analysts LLC first reported a position in Accendra Health in Q2 2013 and held it in 13 quarters.
  • Capital Analysts LLC's Accendra Health position peaked at $192K in Q1 2016.
  • 285 funds tracked by Wall St. Rank held Accendra Health as of Q3 2016.

Based on Capital Analysts LLC's 13F filing for Q3 2016, filed 14 Nov 2016.